iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Alembic Pharma Q2 PAT falls 19% YoY; R&D spend at Rs 168 crore

11 Nov 2022 , 02:21 PM

On the segmental front, API revenue was Rs 294 crore (up 23% YoY). In the Formulations business, US revenue was Rs 418 crore (up 20% YoY), India revenue was Rs 549 crore (up 8% YoY) and Ex-US revenue was Rs 215 crore (up 9% YoY). EBIDTA fell by 12% to Rs 231 crore in Q2 FY23 from Rs 263 crore in Q2 FY22. EBIDTA margin was 16% in Q2 FY23 as against 20% in Q2 FY22. R&D expenses aggregated to Rs 168 crore in the second quarter. Capex spend in the July-September 2022 quarter was Rs 131 crore. Pranav Amin, managing director, Alembic Pharmaceuticals, said: ?It was a satisfactory quarter led by growth in all the verticals of the company, in particular the API business outperformed with a 23% growth during the quarter.? Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. The company manufactures and markets generic pharmaceutical products all over the world. The scrip rose 2.53% to currently trade at Rs 631.65 on the BSE. Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.